Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent n-type calcium channel subunit alpha-1b small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.52 investigational antagonist
cilnidipine voltage-gated calcium channel alpha cav2.2 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.52 phase 3 unknown
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
cilnidipine voltage-dependent l-type calcium channel small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Disease Management[MeSHID:D019468]
Blood Vessel[MeSHID:D001808]
Diabetes Mellitus[MeSHID:D003920]
Blood Pressure[MeSHID:D001794]
Blood[MeSHID:D001769]
Heart[MeSHID:D006321]
Chronic Kidney Diseases[MeSHID:D051436]
Albuminuria[MeSHID:D000419]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA investigational antagonist
click here to return to the previous page